DATAIKU
24.5.2023 11:01:30 CEST | Business Wire | Press release
According to research run by Dataiku, the platform for Everyday AI, the power of data and AI is becoming increasingly available to non-technical employees at companies across EMEA.
The survey, which was run across the United Kingdom, France, the Netherlands, Germany, and the United Arab Emirates, polled over 700 senior decision makers of companies actively using data science platforms and AI models across the enterprise.
It identified a growing trend of empowered non-technical users working with data and AI to make pivotal business decisions. Forty seven percent of EMEA leaders indicated that their non-technical business users have full access to data and AI to attain business goals, and a further 49% stated that business users have at least some access. Eighty four percent of these companies across EMEA said that they are using low- and no-code platforms to achieve these AI goals.
Dataiku Senior Vice President and General Manager, Gregory Herbert, commented: “We’ve seen a great shift in accessibility via the use of low- and no-code platforms, but for many companies, there’s still extensive untapped potential when it comes to making data and AI available to non-technical business users. What we really want to see is AI that is so ingrained and intertwined with the workings of the day-to-day that it’s just part of the business — not only being used or developed by data scientists. If enterprises want to see a deeper transformation and truly data-driven business results, Everyday AI must become a reality for non-data-focused roles.”
AI Drives Momentum Despite Economic Volatility
The majority of companies (79%) surveyed across EMEA indicated they are leveraging AI to its full capacity, and more than 80% of firms indicated that they are able to measure the ROI of their AI investments.
The survey also indicated continued momentum with AI across EMEA. While leaders indicated that business acceleration (50%) and staying ahead of the competition (36%) were the initial top reasons for investing in AI, 2023 has seen a marked shift in AI business goals. When asked what the top three business goals companies were looking to achieve with AI over the next five years, innovation won out (59%), followed by cost reduction (49%) and increased revenue (48%.)
How Will the European Union’s New AI Regulation Impact Business?
The upcoming EU AI regulation requires that any business that commercialises an AI system as a service or a product on the European market conduct a risk assessment to identify risks for all AI systems across the enterprise. This includes any risk surrounding data quality, transparency, human oversight, and accountability.
While there have been criticisms of the EU AI Act’s potential impact on AI innovation, the survey revealed that nearly 80% of respondents did not feel it would hinder innovation and, rather, would introduce new opportunities.
-ENDS-
About Dataiku
Dataiku is the platform for Everyday AI that allows companies to leverage one central solution to design, deploy, govern, and manage AI and analytics applications. Since its founding in 2013, the company has been the leader in democratizing data and empowering organization-wide collaboration. Today, more than 500 companies worldwide use Dataiku to integrate and streamline their use of data, analytics, and AI, driving diverse use cases from fraud detection and customer churn prevention, to predictive maintenance and supply chain optimization. Stay connected with us on our blog, Twitter (@dataiku) and on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230524005027/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Secures €50M Financing to Accelerate Global Growth30.3.2026 08:00:00 CEST | Press release
€50 million financing package from funds and accounts managed by BlackRock will support IQM to scale operations, accelerate product development, and strengthen its market position. The facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing as IQM prepares for public listing. IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), today announced it has secured a €50 millionfinancing package from funds and accounts managed by BlackRock. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329996942/en/ IQM Radiance quantum computer is located in IQM's showroom in Espoo, Finland. This facility will support acceleration of IQM’s technology roadmap, fuel R&D, support entry into additional markets, and advance IQM’s leadership in quantum computing. This
Bureau Veritas and Trade Technologies Join Forces to Streamline Global Trade Operations30.3.2026 07:45:00 CEST | Press release
Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), through its Swiss branch Government Services Division, is pleased to announce a strategic agreement with Trade Technologies, the leading provider of trade finance automation, connectivity and transaction management services. This collaboration is a significant step toward reducing the complexities of international trade operations, particularly in regions where regulatory and inspection controls remain stringent. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260329411683/en/ Addressing Critical Trade Finance Challenges The agreement comes at a pivotal time for global trade. Letters of Credit (LCs) continue to serve as essential instruments in international commerce, particularly across the Middle East and Africa, where counterparty risk, foreign exchange controls, sanctions exposure, and regulatory oversight face ongoing challenges. In
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release
~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom